EHD2, a novel HIF target gene, is a promising biomarker in clear cell renal cell carcinoma
CONCLUSION: EHD2 is a novel HIF target, based on a relatively large sample of EHD2 research in patients with ccRCC. Furthermore, our study provided evidence that EHD2 can serve as a promising biomarker for predicting ccRCC outcome.PMID:38059172 | PMC:PMC10695750
Source: International Journal of Clinical and Experimental Pathology - Category: Pathology Authors: Yufeng Chen Song Xue Jian Shi Chunfeng He Qingchuan Zhang Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clear Cell Carcinoma | Databases & Libraries | Genetics | Kidney Cancer | Pathology | Renal Cell Carcinoma | Study | Urology & Nephrology